Kirby Humbles, NP
Adult Health · Baton Rouge, LANPI 1770580060
Payments from drug & device makers
Across 86 payments — averaging $17.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$490
- Novo Nordisk$157
- Braeburn Inc.$132
- Abbott$115
- Regeneron Healthcare Solutions, Inc.$113
- Biohaven Pharmaceuticals, Inc.$70
- plus $446 from 16 others
What the payments were for
- Food & beverage$1,523100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 40 | $490 |
| Novo Nordisk | 11 | $157 |
| Braeburn Inc. | 3 | $132 |
| Abbott | 1 | $115 |
| Regeneron Healthcare Solutions, Inc. | 1 | $113 |
| Biohaven Pharmaceuticals, Inc. | 5 | $70 |
| Medtronic | 1 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| Orexo US, Inc. | 3 | $50 |
| Alkermes, Inc. | 2 | $47 |
| Amgen | 3 | $43 |
| Merck | 2 | $33 |
| Boehringer Ingelheim | 2 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $21 |
| GSK | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Acerus Pharmaceuticals Corporation | 1 | $15 |
| Scynexis, Inc. | 1 | $14 |
| Nestle Healthcare Nutrition Inc. | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FREESTYLE LIBRE 3$115
- DUPIXENT$113
- BRIXADI$110
How this compares
$1,523 in reported general payments places this provider in the 60th percentile of 203 adult health providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 31 | $5,526 |
| Buprenorphine Hcl | 16 | $1,651 |
| Gabapentin | 16 | $77 |
| Diazepam | 13 | $72 |
| Clonazepam | 14 | $32 |
Paid to pharmacies, not to this prescriber.
Other adult health in Baton Rouge
- Joan SmithBaton Rouge$121K
- Deborah SmithBaton Rouge$18K
- Tanisha SmithBaton Rouge$17K
- Eva Marina StaffordBaton Rouge$15K
- Dustin DenicolaBaton Rouge$14K
- Wendy GillBaton Rouge$13K
- Jennifer LeblancBaton Rouge$12K
- Carrie PerryBaton Rouge$6K
- Auldyn HirscheyBaton Rouge$6K
- Colette BlanchardBaton Rouge$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.